section name header

Y-Site Injection Compatibility (1:1 Mixture)

Imipenem-cilastatin sodium

(Mfr: ME)(Conc: 5 mg/mLa,h)

I

Telavancin HCl

(Mfr: ASP)(Conc: 7.5 mg/mLa)

Remarks:

Slight measured turbidity increase

Ref:

2830